Spectral Medical Inc. (TSX:EDT)
1.420
+0.010 (0.71%)
Oct 9, 2025, 4:00 PM EDT
Spectral Medical Revenue
Spectral Medical had revenue of 813.00K CAD in the quarter ending June 30, 2025, with 72.61% growth. This brings the company's revenue in the last twelve months to 2.53M, up 33.19% year-over-year. In the year 2024, Spectral Medical had annual revenue of 2.29M with 43.05% growth.
Revenue (ttm)
2.53M
Revenue Growth
+33.19%
P/S Ratio
161.49
Revenue / Employee
87.31K
Employees
29
Market Cap
408.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.29M | 688.00K | 43.05% |
Dec 31, 2023 | 1.60M | -69.00K | -4.14% |
Dec 31, 2022 | 1.67M | -329.00K | -16.48% |
Dec 31, 2021 | 2.00M | -105.00K | -5.00% |
Dec 31, 2020 | 2.10M | -767.00K | -26.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
Trulieve Cannabis | 1.62B |
dentalcorp Holdings | 1.62B |
Sienna Senior Living | 929.68M |
WELL Health Technologies | 1.12B |
Cronos Group | 177.69M |
Extendicare | 1.51B |
Spectral Medical News
- 10 days ago - Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF - GlobeNewsWire
- 23 days ago - Spectral Medical Announces Publication of EDEN Observational Study - GlobeNewsWire
- 4 weeks ago - Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025 - GlobeNewsWire
- 6 weeks ago - Spectral Medical Receives US$3 Million From Vantive - GlobeNewsWire
- 2 months ago - Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock - GlobeNewsWire
- 2 months ago - Spectral Medical GAAP EPS of $0.00, revenue of $0.81M - Seeking Alpha
- 2 months ago - Spectral Medical Announces Second Quarter and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Spectral Medical Inc. Announces Filing of Base Shelf Prospectus - GlobeNewsWire